A1503650
Indobufen , ≥97% , 63610-08-2
CAS NO.：63610-08-2
Empirical Formula: C18H17NO3
Molecular Weight: 295.34
MDL number: MFCD00572250
EINECS: 264-364-4
| Pack Size | Price | Stock | Quantity |
| 50mg | RMB55.20 | In Stock |
|
| 250mg | RMB159.20 | In Stock |
|
| 5mg | RMB165.60 | In Stock |
|
| 1g | RMB399.20 | In Stock |
|
| 100mg | RMB413.60 | In Stock |
|
| 5g | RMB1199.20 | In Stock |
|
| 10g | RMB1893.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 182-184° |
| Boiling point: | 518.1±50.0 °C(Predicted) |
| Density | 1.275±0.06 g/cm3(Predicted) |
| storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 4.39±0.10(Predicted) |
| color | White |
| InChI | InChI=1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) |
| InChIKey | AYDXAULLCROVIT-UHFFFAOYSA-N |
| SMILES | O=C1C2C=CC=CC=2CN1C1C=CC(C(CC)C(=O)O)=CC=1 |
Description and Uses
Indobufen is a platelet aggregation inhibitor related to the antiinflammatory agent indoprofen. It has shown clinical efficacy in peripheral artery disease, in prevention of deep vein thrombosis after myocardial infarction, and in blocking excercise-induced increase in platelet aggregation in angina patients.
Indobufen is a platelet aggregation inhibitor. Indobufen is the anticoagulant drug and platelet aggregation inhibitor, which has anti-inflammatory analgesic effect. Indobufen is used as an antithrombotic.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P280-P305+P351+P338 |
